Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Short

Showing results (531-540 of 544) with videos related to

Pageof 55
Sort By:
Antimicrobial Agents and Chemotherapy|September 29, 2005
Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitorRobert G Ferris, Richard J Hazen, Grace B Roberts, et al.
ACS Applied Materials & Interfaces|June 17, 2017
Tunable Surface Repellency Maintains Stemness and Redox Capacity of Human Mesenchymal Stem CellsDaniel A Balikov, Spencer W Crowder, Timothy C Boire, et al.
Clinical Immunology (Orlando, Fla.)|October 18, 2023
Multi-omic profiling reveals early immunological indicators for identifying COVID-19 ProgressorsKatherine A Drake, Dimitri Talantov, Gary J Tong, et al.
Translational Psychiatry|September 28, 2016
Cerebral [<sup>18</sup> F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathyD L Dickstein, M Y Pullman, C Fernandez, et al.
Pain|July 5, 2021
Pain is common after sexual assault and posttraumatic arousal/reactivity symptoms mediate the development of new or worsening persistent painNicole A Short, Andrew S Tungate, Kenneth A Bollen, et al.
Depression and Anxiety|October 8, 2020
Health care utilization by women sexual assault survivors after emergency care: Results of a multisite prospective studyNicole A Short, Megan Lechner, Benjamin S McLean, et al.
Journal of Medicinal Chemistry|February 20, 2004
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1Joseph H Chan, George A Freeman, Jeffrey H Tidwell, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.
Journal of Medicinal Chemistry|June 1, 2001
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1J H Chan, J S Hong, R N Hunter, et al.
Molecular Psychiatry|February 26, 2020
Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposureDara L Dickstein, Rita De Gasperi, Miguel A Gama Sosa, et al.
Pageof 55

Showing results (531-540 of 544) with videos related to

Sort By:
Pageof 55
Antimicrobial Agents and Chemotherapy|September 29, 2005
Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitorRobert G Ferris, Richard J Hazen, Grace B Roberts, et al.
ACS Applied Materials & Interfaces|June 17, 2017
Tunable Surface Repellency Maintains Stemness and Redox Capacity of Human Mesenchymal Stem CellsDaniel A Balikov, Spencer W Crowder, Timothy C Boire, et al.
Clinical Immunology (Orlando, Fla.)|October 18, 2023
Multi-omic profiling reveals early immunological indicators for identifying COVID-19 ProgressorsKatherine A Drake, Dimitri Talantov, Gary J Tong, et al.
Translational Psychiatry|September 28, 2016
Cerebral [<sup>18</sup> F]T807/AV1451 retention pattern in clinically probable CTE resembles pathognomonic distribution of CTE tauopathyD L Dickstein, M Y Pullman, C Fernandez, et al.
Pain|July 5, 2021
Pain is common after sexual assault and posttraumatic arousal/reactivity symptoms mediate the development of new or worsening persistent painNicole A Short, Andrew S Tungate, Kenneth A Bollen, et al.
Depression and Anxiety|October 8, 2020
Health care utilization by women sexual assault survivors after emergency care: Results of a multisite prospective studyNicole A Short, Megan Lechner, Benjamin S McLean, et al.
Journal of Medicinal Chemistry|February 20, 2004
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1Joseph H Chan, George A Freeman, Jeffrey H Tidwell, et al.
Journal of Medicinal Chemistry|November 13, 2004
Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 2George A Freeman, C Webster Andrews Iii, Andrew L Hopkins, et al.
Journal of Medicinal Chemistry|June 1, 2001
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1J H Chan, J S Hong, R N Hunter, et al.
Molecular Psychiatry|February 26, 2020
Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposureDara L Dickstein, Rita De Gasperi, Miguel A Gama Sosa, et al.
Pageof 55